Stock Research for ALXN

ALXN

Featured Broker: Ally Invest

Get the due diligence for another stock.

 

ALXN Stock Chart & Research Data

The ALXN chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the ALXN chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


 


ALXN Due diligence Resources & Stock Charts

The ALXN stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View ALXN Detailed Price Forecast - CNN Money CNN View ALXN Detailed Summary - Google Finance
Yahoo View ALXN Detailed Summary - Yahoo! Finance Zacks View ALXN Stock Research & Analysis - Zacks.com

Stock Analysis

TradeIdeas View ALXN Trends & Analysis - Trade-Ideas Barrons View ALXN Major Holders - Barrons
NASDAQ View ALXN Call Transcripts - NASDAQ Seeking View ALXN Breaking News & Analysis - Seeking Alpha
Spotlight View ALXN Annual Report - CompanySpotlight.com OTC Report View ALXN OTC Short Report - OTCShortReport.com
TradeKing View ALXN Fundamentals - TradeKing Charts View ALXN SEC Filings - Bar Chart
WSJ View Historical Prices for ALXN - The WSJ Morningstar View Performance/Total Return for ALXN - Morningstar
MarketWatch View the Analyst Estimates for ALXN - MarketWatch CNBC View the Earnings History for ALXN - CNBC
StockMarketWatch View the ALXN Earnings - StockMarketWatch MacroAxis View ALXN Buy or Sell Recommendations - MacroAxis
Bullish View the ALXN Bullish Patterns - American Bulls Short Pains View ALXN Short Pain Metrics - ShortPainBot.com

Social Media Mentions

StockTwits View ALXN Stock Mentions - StockTwits PennyStocks View ALXN Stock Mentions - PennyStockTweets
Twitter View ALXN Stock Mentions - Twitter Invest Hub View ALXN Investment Forum News - Investor Hub
Yahoo View ALXN Stock Mentions - Yahoo! Message Board Seeking Alpha View ALXN Stock Mentions - Seeking Alpha


Financial & Transaction Holdings

SECform4 View Insider Transactions for ALXN - SECform4.com Insider Cow View Insider Transactions for ALXN - Insider Cow
CNBC View ALXN Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for ALXN - OTC Markets
Yahoo View Insider Transactions for ALXN - Yahoo! Finance NASDAQ View Institutional Holdings for ALXN - NASDAQ


Stock Charts

FinViz View ALXN Stock Insight & Charts - FinViz.com StockCharts View ALXN Investment Charts - StockCharts.com
BarChart View ALXN Stock Overview & Charts - BarChart Trading View View ALXN User Generated Charts - Trading View




Latest Financial News for ALXN


Has Alexion Pharmaceuticals (ALXN) Outpaced Other Medical Stocks This Year?
Posted on Thursday August 15, 2019

Is (ALXN) Outperforming Other Medical Stocks This Year?


Amgen (AMGN) Soars to 52-Week High, Time to Cash Out?
Posted on Wednesday August 14, 2019

Amgen (AMGN) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.


Zacks Industry Outlook Highlights: Gilead Sciences, Regeneron Pharmaceuticals, Amgen, Vertex Pharmaceuticals and Alexion Pharmaceuticals
Posted on Wednesday August 14, 2019

Zacks Industry Outlook Highlights: Gilead Sciences, Regeneron Pharmaceuticals, Amgen, Vertex Pharmaceuticals and Alexion Pharmaceuticals


Canadian drug price regulator may be flexible on rare diseases
Posted on Tuesday August 13, 2019

Canada's patented drug price regulator, set to gain new powers next year, may be "more forgiving" in setting price caps for drugs that treat rare diseases, the agency's executive director told Reuters, as some advocates warned the country's pricing reforms would hurt patients. The Canadian government announced final regulations meant to cut drug spending on Friday. The reforms expand the Patented Medicine Prices Review Board's (PMPRB) powers, and among other things give it the ability to consider the cost-effectiveness of medications.


Stock Market & Investing Books

Enter a stock symbol to view the stock details.